Thank you!
Your support is sustaining the future of local news in our communities.

Future of weight loss

More than 40% of Americans are now classified as obese while 75% of adults are either overweight or obese. A new group of drugs called GLP-1 receptor agonists have come on the scene to help in the battle to lose weight. Are they as good as we think?

You may have heard about them or some of their brand names like Zepbound, Wegovy, and Ozempic. The use of these drugs has exploded in popularity to the point where companies like Lilly and Novo Nordisk have had problems keeping up with demand. There is nothing magical about the science behind these drugs. GLP-1 mimics a protein naturally produced by our small intestines. The receptors for these medicines are located across the body. They help us lose weight because receptors in the gastrointestinal tract slow down and send signals to the brain that give us a sense of feeling full.

There are some side effects but nothing too serious for most patients. We are still learning how these medications impact the body. They are currently approved for treating diabetes, obesity, and those with a history of cardiovascular disease in people who are overweight. There are a few drawbacks to these drugs at present.

Typically, GLP-1 agonists are administered as injections in the abdomen, upper arms, outer thighs, or upper buttocks via a syringe and needle or a pre-filled dosing pen. The shots are generally taken once a day or once a week.

For many, this is a big turn-off. Fortunately, you will be able to take tablets soon. The typical weight loss is from 5-15% of body weight over at least 12 months. But GLP-1 is no quick fix. Like exercise, you must stick with it. If you stop taking it, most people regain the weight they lost. And you can’t expect to magically lose weight while you continue to eat all that junk food you get.

The second drawback is the expense. These medications’ list price is around $1,000 a month to $1,400 a month. Without insurance, we are talking $12,000 plus per year for these drugs. Many insurance plans cover some portion of GLP-1 costs, but the extent of coverage can vary significantly. You probably are wondering whether Medicare covers GLP-1 medications. They do for certain medically accepted indications such as heart attack or cardiovascular disease but not for weight management. To qualify, you must have a BMI of 30 or higher, or 27 or higher with comorbidities like high blood pressure, high cholesterol, or type 2 diabetes. They are currently covered through Part D plans.

An entirely new team of individuals, including a retired congressman, a surgeon, and a talk-show host could play pivotal roles in how the government goes about safeguarding America’s health.

Coinsurance amounts are pegged to the list price of drugs. As such, Medicare beneficiaries who qualify could still face monthly costs of $250 to $430 before they reach the annual out-of-pocket drug spending established by the Inflation Reduction Act (IRA). The IRA cap for out-of-pocket expenses were around $3,300 in 2024 and will be $2,000 in 2025. Most retirees living on modest incomes would still find the cost of GLP-1 prohibitive.

In November 2024, the Biden Administration proposed that Medicare and Medicaid cover obesity medications. In doing so, they sidestepped a twenty-year-old piece of legislation that prevented Medicare from covering drugs for ‘weight loss.’ The new proposal specifies that the drugs would be covered to treat the disease of obesity and prevent related conditions. Those conditions are serious and include diabetes, high blood pressure, cardiovascular disease, sleep apnea, fatty liver disease, and arthritis.

The classification would also mean that every state Medicaid program would be required to cover the drugs starting in 2026. Between the two programs, an additional 7.4 million Americans would gain coverage. The price tag would be high, at least $36 billion over a decade. However, there are more obesity drugs in the pipeline and prices should fall as competition heats up. Starting in 2025, Medicare will also be able to negotiate a lower price for Wegovy as well as many other popular drugs.

As for the future, the costs and usage of GLP-1 medications could change significantly under the second Trump Administration. An entirely new team of individuals, including a retired congressman, a surgeon, and a talk-show host could play pivotal roles in how the government goes about safeguarding America’s health.

Under Robert F. Kennedy, an environmental lawyer, politician, and anti-vaccine organizer, we can expect radically different views and actions in health care, medicine, food safety, and science research. Early indications are that Kennedy, who would run the Department of Health and Human Services, is not a big fan of Ozempic. He does not believe that using popular GLP-1 drugs is ever going to make America healthy again. His remedy would be to provide good food to Americans. He believes that providing three nutritious meals a day to all Americans would solve obesity and diabetes overnight. The problem is that for many Americans the admonition to change your diet, eat less, and exercise more has failed to dent the problem. Why not give the country an avenue that shows a much better chance of success over the long term?



Bill Schmick is a founding partner of Onota Partners, Inc., in the Berkshires.

The views expressed here are not necessarily those of The Millerton News and The News does not support or oppose candidates for public office.

Latest News

Historic farmhouse enters new chapter as a home for agricultural education

Mindy Yang points to wildflowers growing at Silverbrook Manor, the Millbrook home where she and her husband, William Harris, operate a community-supported agriculture operation.

Photo By Nathan Miller

MILLBROOK — The scent of citrus, emanating from a discreet diffuser tucked along the wall, fills the air upon entering the historic farmhouse at Silverbrook Manor, where perfume expert Mindy Yang and her husband, William Harris, have started to build a life centered on regenerative agriculture and education.

It’s a fitting introduction to the couple and their property — a centuries-old farm that raised dairy cattle before the American Revolution and horses for decades afterward. Over glasses of cold water infused with mint from their garden, the couple described the property as a collision of eras and visions, blending Yang’s passion for scents, food and natural medicines with Harris’s interior design skills and love of history.

Keep ReadingShow less
Dick Hermans to receive the Estabrook Community Leadership Award

Dick Hermans, right, celebrating Oblong Books’ 50th birthday.

Photo by Aly Morrissey

FALLS VILLAGE — The Lakeville Journal and The Millerton News will present the 2026 Estabrook Community Leadership Award to Dick Hermans at the annual Jubilee celebration on October 11 at the Sharon Playhouse.

The award honors outstanding leadership in community service. Joan Osofsky and Suzanna Hermans are serving as co-chairs of the event. More than 50 community members, reflecting Dick’s wide influence and his support of writers, editors and publishers, have joined the Host Committee to support both Dick’s recognition and the annual fundraising effort for The Lakeville Journal and The Millerton News.

Keep ReadingShow less
Millerton native to lead 175th comedy night

Ronnie Reed

Photo Provided

MILLERTON — A village native who has long been known as the local funny man is putting his comedic skills to work this summer at Millerton 175’s comedy night.

Ronnie Reed, 39, the headliner of Millerton 175’s comedy night on July 16, said he’s been telling jokes and making people laugh for as long as he can remember.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Eight apartments proposed on Route 44 tests North East’s new zoning code

MILLERTON — Eight apartments could become the first homes built under North East’s new Route 44 zoning regulations, marking the start of a development strategy designed to bring housing to the town’s commercial corridor.

Local petroleum distributor GRJH Inc. presented plans to the Planning Board on Wednesday, June 24, to convert a two-story office building it has owned since 1997 into an eight-unit apartment building.

Keep ReadingShow less
Dance workshop teaches kids Hispanic folkloric dance

Karina Powers teaches the Dances of Chihuahua workshop class in the Stissing Center’s Banning Hall. She led a group of five children and their supporters, teaching them about the region of Chihuahua and walking them through a cultural dance.

Photo by Lucia Iandolo

PINE PLAINS — Children and families from across the Taconic region learned the cultural dances of Chihuahua, Mexico, as part of a series of events geared toward children throughout the summer.

Karina Powers of Red Hook’s Dance and Theater Arts Center and the Stissing Center for Arts and Culture held the “Dances of Chihuahua” workshop on Saturday aimed at teaching children in the community about Hispanic dances and culture.

Keep ReadingShow less

Prehistoric party

Prehistoric party
Photo By Leila Hawken

Cristian Canmano presented an engaging Dinosaurs Rock program complete with genuine prehistoric artifacts, educational and entertainment for both kids and adults at the Millbrook Library on Saturday, June 27.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.